Table 1.
Baseline characteristics of PLWHIV vs. uninfected individuals
| PLWHIV (n=209) |
uninfected (n=168) |
P value | |
|---|---|---|---|
| Age (mean±SD) | 45.6±10 | 43.1±17 | 0.07 |
| Male sex | 150(72) | 109(65) | 0.18 |
| Race | 0.02 | ||
| White | 106(51) | 30(65) | |
| Black | 73(35) | 5(11) | |
| Asian | 4(2) | 2(1) | |
| Other | 19(9) | 6(13) | |
| Hispanic/Latino | 27(13) | 3(6) | 0.35 |
| Diabetes mellitus | 20(10) | 19(11) | 0.61 |
| Hypertension | 46(22) | 53(31) | 0.04 |
| Hyperlipidemia | 31(15) | 28(17) | 0.67 |
| Current Smoker | 71(33) | 51(30) | 0.57 |
| Family history of CAD | 10(6) | 2(1) | 0.07 |
| Family history of stroke/TIA | 11(5) | 7(5) | 1.00 |
| Number of risk factors | |||
| 0 | 82(21) | 107(28) | <0.001 |
| 1 | 93(25) | 30(8) | |
| 2 | 20(5) | 21(6) | |
| 3 | 12(3) | 10(3) | |
| 4 | 2(1) | 0(0) | |
| IVDU | 0.01 | ||
| Current | 17(8) | 0(0) | |
| Past | 19(9) | 0(0) | |
| Cocaine use | <0.01 | ||
| Current | 17(8) | 0(0) | |
| Past | 35(17) | 2(4) | |
| CV Medications | |||
| Aspirin | 19(9) | 15(9) | 1.00 |
| ACE inhibitor | 19(9) | 15(9) | 1.00 |
| ARB | 5(1) | 2(1) | 0.46 |
| Betablocker | 30(14) | 18(11) | 0.35 |
| Statin | 27(12) | 18(11) | 0.74 |
*
Values are mean±SD or n (%). CAD: coronary artery disease, TIA: transient ischemic attack, IVDU: intravenous drug use, ACE: angiotensin converting enzyme, ARB: angiotensin receptor blocker, HDL: high density lipoprotein, LDL: low density lipoprotein, BMI: body mass index